Dialysis Corporation of America Announces Acquisition of Maryland Dialysis Center
LINTHICUM, Md.,
America (Nasdaq: DCAI) announced the acquisition of a dialysis center in
Rehabilitation Center, where it can treat patients from both within the St.
Thomas More Center, as well as the surrounding community.
This new center has 24 treatment stations and is currently caring for
approximately 145 dialysis patients. The company is considering adding six
more stations to the facility, which will accommodate up to an additional 36
patients.
President & CEO
is strategic to DCA as we begin 2009. It marks our fourth facility located on
the campus of a skilled nursing facility, and our sixth in
remains a focused market for DCA. Additionally, we are very fortunate to be
inheriting a great group of caregivers in a community with several excellent
nephrologists.”
Dialysis Corporation of America owns and operates freestanding kidney
hemodialysis centers located in
services on a contract basis to certain hospitals located in the those states.
The company provides patients with their choice of a full range of quality in-
center, acute or at-home hemodialysis services.
This release contains forward-looking statements that are subject to risks
and uncertainties that could affect the business and prospects of the company
and cause actual results and plans to differ materially from those
anticipated. Those factors include, but are not limited to, increases in
interest rates, the possible need for and availability of additional
financing, the company’s satisfying the covenants and conditions of its credit
facility, certain delays beyond the company’s control with respect to future
business events, the highly competitive environment in the establishment and
operation of dialysis centers, the ability to develop or acquire additional
dialysis facilities, whether patient bases of the company’s dialysis
facilities can mature to provide profitability, the extensive regulation of
dialysis operations, government rate determination for Medicare reimbursement,
pricing pressure from private payors, and other risks detailed in the
company’s filings with the SEC, particularly as described in the company’s
annual report on Form 10-K for the fiscal year ended
historical results contained in this press release are not necessarily
indicative of future performance of the company.
Other Dialysis Corporation of America press releases, corporate profile,
corporate governance materials, quarterly and current reports, and other
filings with the Securities and Exchange Commission are available on Dialysis
Corporation of America’s internet home page:
http://www.dialysiscorporation.com.
CONTACT: For additional information, you may contact Dialysis Corporation
of America, 1302 Concourse Drive, Suite 204, Linthicum, MD 21090; Telephone
Number (410) 694-0500; Attention: Investor Relations.
SOURCE Dialysis Corporation of America